A clinic ad may mislead. Its main message may be false or lack proof. This can come from its words or images. It can also come from reviews or facts left out. Use this guide before an ad goes live. It cannot prevent every complaint or legal issue.
What makes a medical clinic advertisement misleading?
An ad must be true and not mislead people. A clinic needs proof for each factual claim. It must have that proof before it shares the ad (Federal Trade Commission [FTC], 2022).
Look at the ad as a whole. The FTC calls this its net impression. It covers direct claims. It also covers implied claims in all forms of promotion (FTC, 2022).
A true sentence can still give a false message. Take “same week visits.” Does that apply to each doctor? Does it apply to each site and service? If not, the ad must state the real limit in a clear way.
Ask what a new patient may believe. A small note should not fight with the main claim.
Which claims need proof before publication?
Health and safety claims often need sound science. The proof must fit the exact service. It must also fit the exact claim (FTC, 2022). One patient story is not enough.
“Most patients improve in four weeks” makes claims about both rate and time. The clinic needs good support for each one. A refund promise does not replace proof.
Keep a claim file. Save the ad, source, date, limits, and approval. The healthcare compliance glossary can help staff keep review terms apart.
How should reviews and patient stories be handled?
The federal Reviews and Testimonials Rule took effect on October 21, 2024. It covers set acts tied to fake or paid reviews. It also covers some insider ties, review control, and fake social signals (FTC, 2024).
A clinic ad may feature a patient review. Under this rule, the clinic then uses it as a testimonial. It is not just a hosted review (FTC, 2024). The rule's exact scope still controls. The review cannot make a claim that the clinic could not make on its own.
Do not offer a gift only for a good review. An offer cannot require a positive or negative view, even by hint (FTC, 2024). Staff and family ties may need a clear notice. Not every review issue breaks each part of the rule.
Patient data brings a second check. HIPAA generally requires written approval for marketing. This applies before a covered clinic uses or shares protected health data. Set exceptions apply (U.S. Department of Health and Human Services, Office for Civil Rights [OCR], n.d.). Third-party payment may need to be named in that approval (OCR, n.d.). See the HIPAA privacy glossary for key terms.
How should FDA, credential, network and price claims be checked?
Use exact FDA terms. FDA does not approve doctors' offices or labs (U.S. Food and Drug Administration [FDA], n.d.). A listing is not approval. A registration is not approval. A compounded drug is not FDA approved. Device clearance may also differ from approval (FDA, n.d.).
Check each license and board claim in the right state. California limits who may use “board certified” in an ad (Medical Board of California, n.d.-b). That rule is not national.
Check network claims against the current contract and directory. Confirm the doctor, site, service, and date. “We take your insurance” may hide the real network status.
For a price claim, name what the price includes. State key limits, end dates, and added fees. A “free,” “lowest,” or “guaranteed” claim needs proof for the full offer.
What should a clinic review before an ad goes live?
Use one short review sheet. Name who approved each item.
| Ad item | What to check | Review owner |
|---|---|---|
| Result claim | Exact words and implied promise | Clinical reviewer. |
| Proof | Source fits the service and claim | Compliance lead. |
| Review or story | Real account, consent, and ties | Marketing and compliance. |
| Patient data | Valid approval or a clear exception | Privacy lead. |
| FDA words | Approval, clearance, listing, or registration | Compliance lead. |
| Credentials | Current license, board, state, and field | Credentialing lead. |
| Network claim | Contract, directory, doctor, site, and service | Contract lead. |
| Price or deal | Full terms, limits, fees, and dates | Finance lead. |
Made-up example: A clinic drafts “FDA approved weight loss program.” It uses a compounded drug. The reviewer removes the claim because compounded drugs are not FDA approved (FDA, n.d.). Counsel then checks the new words. The example does not decide the law, result, coverage, network status, or payer action.
Where can a complaint or referral go?
No sound national source was found that ranks payer reports by how often they occur. These are risk areas, not a “top ten” list.
A complaint is not proof. A report, audit, or letter is not a final finding. The right path turns on the act and state. It also turns on the profession, program, and contract.
The FTC has a public report portal (FTC, n.d.). Anyone may file a HIPAA or Part 2 complaint that fits OCR's scope (OCR, 2026).
HHS-OIG accepts tips from all sources. These tips may cover fraud, waste, or abuse in HHS programs (U.S. Department of Health and Human Services, Office of Inspector General [OIG], n.d.). An ad error alone is not federal fraud.
State boards may also act. California lists public, trade, and government sources. It names a misleading ad as one possible issue (Medical Board of California, n.d.-a). Other boards may use other rules.
If a payer raises a concern, save the exact ad and all support. Keep the first version, dates, approvals, and replies. Do not erase or alter proof. A post-payment review guide explains why a review does not itself prove an error.
Frequently asked questions
Can a disclaimer fix a misleading headline?
Not always. A note may fail if people still get a false main message (FTC, 2022). Change the headline or offer when the limit cannot be made clear.
Can an insurer or payer report a clinic?
Possibly. A payer may be able to use a route allowed by its contract or program. A board or agency may have a route too. The facts and rules control. This is not a payer duty. A report does not prove a breach. Keep the ad and support. Send the matter to the right reviewer. Reply within any date the actual contract or agency notice sets.
This guide is general. It is not legal, privacy, payer, contract, or ad advice. A lawyer or compliance expert should review the exact state, profession, contract, and ad.
References
Federal Trade Commission. (n.d.). Report fraud. https://reportfraud.ftc.gov/
Federal Trade Commission. (2022, December). Health products compliance guidance. https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance
Federal Trade Commission. (2024). Rule on the use of consumer reviews and testimonials (16 C.F.R. pt. 465). https://www.ecfr.gov/current/title-16/chapter-I/subchapter-D/part-465
Medical Board of California. (n.d.-a). Complaint process. https://www.mbc.ca.gov/Consumers/File-a-Complaint/complaint-process.aspx
Medical Board of California. (n.d.-b). Physician credentials and practice specialties: Frequently asked questions. https://www.mbc.ca.gov/FAQs/?cat=Consumer&topic=Complaint%3A+Physician+Credentials%2FPractice+Specialties
U.S. Department of Health and Human Services, Office for Civil Rights. (n.d.). Marketing. https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/marketing/index.html
U.S. Department of Health and Human Services, Office for Civil Rights. (2026, February 13). Filing a health information privacy complaint. https://www.hhs.gov/hipaa/filing-a-complaint/index.html
U.S. Department of Health and Human Services, Office of Inspector General. (n.d.). Report fraud, waste, and abuse. https://oig.hhs.gov/fraud/report-fraud/
U.S. Food and Drug Administration. (n.d.). Is it really 'FDA approved'? https://www.fda.gov/consumers/consumer-updates/it-really-fda-approved
